loadpatents
name:-0.032850980758667
name:-0.022636890411377
name:-0.0093069076538086
Klatzmann; David Patent Filings

Klatzmann; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Klatzmann; David.The latest application filed is for "virus-like particles which can be used in the treatment of allergies".

Company Profile
9.22.31
  • Klatzmann; David - Paris FR
  • Klatzmann; David - Paris Cedex FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Virus-like particles which can be used in the treatment of autoimmune diseases
Grant 11,306,294 - Bellier , et al. April 19, 2
2022-04-19
Compositions and methods for treatment of cytomegalovirus
Grant 11,248,026 - Anderson , et al. February 15, 2
2022-02-15
Virus-like Particles Which Can Be Used In The Treatment Of Allergies
App 20210299195 - Bellier; Bertrand ;   et al.
2021-09-30
Combination Of Interleukin-2 With An Interleukin 1 Inhibitor, Conjugates And Therapeutic Uses Thereof
App 20210236599 - Klatzmann; David ;   et al.
2021-08-05
Use Of Interleukin 2 For Treating Sjogren's Syndrome
App 20210121532 - KLATZMANN; David ;   et al.
2021-04-29
Use Of Low Dose Il-2 For Treating Autoimmune-related Or Inflammatory
App 20210038691 - Klatzmann; David ;   et al.
2021-02-11
Virus-like Particles Which Can Be Used In The Treatment Of Autoimmune Diseases
App 20200347363 - Bellier; Bertrand ;   et al.
2020-11-05
Use of low dose IL-2 for treating autoimmune--related or inflammatory disorders
Grant 10,765,723 - Klatzmann , et al. Sep
2020-09-08
Use Of Low Dose Il-2 For Treating Autoimmune - Related Or Inflammatory Disorders
App 20190351023 - Klatzmann; David ;   et al.
2019-11-21
Interleukin-2 for treating food allergy
Grant 10,376,564 - Klatzmann , et al. A
2019-08-13
Genetically Modified T Lymphocytes
App 20190151364 - Klatzmann; David
2019-05-23
Use of low dose IL-2 for treating autoimmune related or inflammatory disorders
Grant 10,293,028 - Klatzmann , et al.
2019-05-21
Use Of Interleukin 2 For Treating Spondyloarthritis
App 20190060407 - Klatzmann; David ;   et al.
2019-02-28
Protozoan Variant-specific Surface Proteins (vsp) As Carriers For Oral Drug Delivery
App 20180228913 - KLATZMANN; David ;   et al.
2018-08-16
Pharmaceutical compositions comprising a polypeptide comprising at least one CXXC motif and heterologous antigens and uses thereof
Grant 9,801,927 - Klatzmann , et al. October 31, 2
2017-10-31
Use Of Low Dose Il-2 For Treating Autoimmune Related Or Inflammatory Disorders
App 20170304402 - Klatzmann; David ;   et al.
2017-10-26
Synthetic viruses and uses thereof
Grant 9,765,304 - Klatzmann , et al. September 19, 2
2017-09-19
Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery
Grant 9,757,471 - Klatzmann , et al. September 12, 2
2017-09-12
Method for stimulating T lymphocytes with IL-2
Grant 9,669,071 - Klatzmann , et al. June 6, 2
2017-06-06
Interleukin-2 For Treating Food Allergy
App 20170020962 - KLATZMANN; DAVID ;   et al.
2017-01-26
Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery
Grant 9,457,096 - Klatzmann , et al. October 4, 2
2016-10-04
Synthetic Viruses And Uses Thereof
App 20140255445 - Klatzmann; David ;   et al.
2014-09-11
Method For Determining A Predictive Function For Discriminating Patients According To Their Disease Activity Status
App 20140236621 - Six; Adrien ;   et al.
2014-08-21
Synthetic viruses and uses thereof
Grant 8,673,612 - Klatzmann , et al. March 18, 2
2014-03-18
Protozoan Variant-specific Surface Proteins (vsp) As Carriers For Oral Drug Delivery
App 20140011739 - KLATZMANN; David ;   et al.
2014-01-09
Use Of Low Dose Il-2 For Treating Autoimmune - Related Or Inflammatory Disorders
App 20140004080 - Klatzmann; David ;   et al.
2014-01-02
Pharmaceutical Compositions Comprising A Polypeptide Comprising At Least One Cxxc Motif And Heterologous Antigens And Uses Thereof
App 20130095133 - Klatzmann; David ;   et al.
2013-04-18
Treating immunodeficiencies by intrathymic injection of nucleotide sequences
Grant 8,394,777 - Sitbon , et al. March 12, 2
2013-03-12
Method For Optimizing Blood Cell Transplants
App 20100233144 - Klatzmann; David ;   et al.
2010-09-16
Treatment Of Tumors Using T Lymphocyte Preparations
App 20100215629 - Cohen; Jose ;   et al.
2010-08-26
.alpha.-.beta. C4BP-type recombinant heteromultimeric proteins
Grant 7,504,483 - Klatzmann , et al. March 17, 2
2009-03-17
Drugs for the Prevention or Treatment of Immunodeficiencies, Autoimmune Diseases or for the Induction of Immune Tolerance
App 20080206210 - Taylor; Naomi ;   et al.
2008-08-28
Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and use thereof
App 20070128670 - Klatzmann; David ;   et al.
2007-06-07
Alpha-beta C4BP -type recombinant heteromultimeric proteins
App 20070015258 - Klatzmann; David ;   et al.
2007-01-18
.alpha.-.beta. C4BP-type recombinant heteromultimeric proteins
Grant 7,074,411 - Klatzmann , et al. July 11, 2
2006-07-11
Highly productive packaging lines
Grant 6,872,528 - Klatzmann , et al. March 29, 2
2005-03-29
Albumin derivatives with therapeutic functions
App 20050048471 - Becquart, Jerome ;   et al.
2005-03-03
Synthetic viruses and uses thereof
App 20040071661 - Klatzmann, David ;   et al.
2004-04-15
Cell therapy using immunoregulatory T-cells
App 20030147865 - Salomon, Benoit ;   et al.
2003-08-07
Albumin derivatives with therapeutic functions
App 20030054554 - Becquart, Jerome ;   et al.
2003-03-20
Highly productive packaging lines
App 20020123146 - Klatzmann, David ;   et al.
2002-09-05
Cells designed as traps and their use as medicines
App 20020090364 - Klatzmann, David
2002-07-11
Host-vector System Which Can Be Used In Gene Therapy
App 20020051763 - KLATZMANN, DAVID ;   et al.
2002-05-02
Compositions of chondrocytes, preparation and utilization
Grant 6,365,405 - Salzmann , et al. April 2, 2
2002-04-02
Albumin derivatives with therapeutic functions
Grant 6,165,470 - Becquart , et al. December 26, 2
2000-12-26
Defective viral vaccine particles obtained in vivo or ex vivo
Grant 6,140,114 - Klatzmann , et al. October 31, 2
2000-10-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed